AR034262A1 - A COMPOSITION TO PROVIDE AN INJECTABLE FLUID MIXTURE, A EQUIPMENT, A METHOD FOR PREPARING A MIXTURE OF SUCH EQUIPMENT, AN APPARATUS FOR THE INTRODUCTION OF A MIXTURE IN A PATIENT - Google Patents

A COMPOSITION TO PROVIDE AN INJECTABLE FLUID MIXTURE, A EQUIPMENT, A METHOD FOR PREPARING A MIXTURE OF SUCH EQUIPMENT, AN APPARATUS FOR THE INTRODUCTION OF A MIXTURE IN A PATIENT

Info

Publication number
AR034262A1
AR034262A1 ARP010104134A ARP010104134A AR034262A1 AR 034262 A1 AR034262 A1 AR 034262A1 AR P010104134 A ARP010104134 A AR P010104134A AR P010104134 A ARP010104134 A AR P010104134A AR 034262 A1 AR034262 A1 AR 034262A1
Authority
AR
Argentina
Prior art keywords
mixture
composition
equipment
patient
collagen
Prior art date
Application number
ARP010104134A
Other languages
Spanish (es)
Original Assignee
Transkaryotic Therapies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transkaryotic Therapies Inc filed Critical Transkaryotic Therapies Inc
Publication of AR034262A1 publication Critical patent/AR034262A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/426—Immunomodulating agents, i.e. cytokines, interleukins, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/438—Antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Composite Materials (AREA)
  • Neurosurgery (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Una composición para proporcionar una mezcla fluida que comprende una población de células de vertebrados (células de un paciente modificas genéticamente para expresar un polipéptido deseado) que expresan un polipéptido suspendida en solución acuosa en una pluralidad de microportadores (microportadores porosos de colágeno o gelatina). Dicha composición que además comprende colágeno soluble, sustancias no colagenosas y una sustancia seleccionada de tejido adiposo desmenuzado, tejido adiposo desmenuzado, tejido omental desmenuzado, metil celulosa, alginato, gelatina y/o fibrita, y que es reintroducida por un sitio subcutáneo al paciente. La composición para proporcionar una mezcla de colágeno fluida que comprende una población de células de vertebrados cultivadas que expresan un polipéptido, suspendida en una solución de colágeno acuosa.A composition for providing a fluid mixture comprising a population of vertebrate cells (cells of a patient genetically modified to express a desired polypeptide) that express a polypeptide suspended in aqueous solution in a plurality of microcarriers (porous microcarriers of collagen or gelatin). Said composition which further comprises soluble collagen, non-collagenous substances and a substance selected from shredded adipose tissue, shredded adipose tissue, shredded omental tissue, methyl cellulose, alginate, gelatin and / or fibrite, and which is reintroduced by a subcutaneous site to the patient. The composition for providing a mixture of fluid collagen comprising a population of cultured vertebrate cells that express a polypeptide, suspended in an aqueous collagen solution.

ARP010104134A 2000-09-14 2001-08-30 A COMPOSITION TO PROVIDE AN INJECTABLE FLUID MIXTURE, A EQUIPMENT, A METHOD FOR PREPARING A MIXTURE OF SUCH EQUIPMENT, AN APPARATUS FOR THE INTRODUCTION OF A MIXTURE IN A PATIENT AR034262A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66203700A 2000-09-14 2000-09-14

Publications (1)

Publication Number Publication Date
AR034262A1 true AR034262A1 (en) 2004-02-18

Family

ID=24656119

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010104134A AR034262A1 (en) 2000-09-14 2001-08-30 A COMPOSITION TO PROVIDE AN INJECTABLE FLUID MIXTURE, A EQUIPMENT, A METHOD FOR PREPARING A MIXTURE OF SUCH EQUIPMENT, AN APPARATUS FOR THE INTRODUCTION OF A MIXTURE IN A PATIENT

Country Status (4)

Country Link
AR (1) AR034262A1 (en)
AU (1) AU2001295028A1 (en)
IL (1) IL148962A (en)
WO (1) WO2002022157A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005045671A1 (en) * 2005-09-15 2007-03-29 Ossacur Ag Use of a collagen of xenogenic origin
GB0524103D0 (en) 2005-11-26 2006-01-04 Medical Res Council Healing
CN107446036A (en) * 2017-09-25 2017-12-08 浙江中医药大学 A kind of enrichment method of platelet cell factor concentration matter
CN110251725A (en) * 2019-08-02 2019-09-20 科先医疗科技(苏州)有限公司 A kind of sodium alginate micro ball packing material and preparation method thereof
WO2023201048A2 (en) * 2022-04-14 2023-10-19 Omeat Inc. Systems and methods of preparing cultivated meat and meat analogs from plant-based proteins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1231277A2 (en) * 1993-04-21 2002-08-14 Institut Pasteur Biocompatible implant for in vivo formation of a neo-organ
US5965125A (en) * 1995-10-25 1999-10-12 Transkaryotic Therapies, Inc. Hybrid matrix implants and explants
EP1221937B1 (en) * 1999-10-05 2004-12-15 Transkaryotic Therapies, Inc. Hybrid matrices and hybrid matrix mixtures

Also Published As

Publication number Publication date
IL148962A (en) 2008-07-08
AU2001295028A1 (en) 2002-03-26
WO2002022157A3 (en) 2003-01-16
WO2002022157A2 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
Yao et al. Enzymatically degradable alginate/gelatin bioink promotes cellular behavior and degradation in vitro and in vivo
Sobreiro-Almeida et al. Decellularized kidney extracellular matrix bioinks recapitulate renal 3D microenvironment in vitro
JP4500898B2 (en) Compositions and methods for producing biological tissues and tissue constructs
Badylak et al. Small intestinal submucosa: a substrate for in vitro cell growth
EP1056836B1 (en) Submucosa gel compositions
Mellor et al. Fabrication and evaluation of electrospun, 3D‐bioplotted, and combination of electrospun/3D‐bioplotted scaffolds for tissue engineering applications
AU2018226406B2 (en) Tissue graft
EP4003439B1 (en) Detergent-free decellularized extracellular matrix preparation method and bioinks for 3d printing
KR102258565B1 (en) Minced cartilage systems and methods
Liang et al. Acellular matrix hydrogel for repair of the temporomandibular joint disc
Spector Musculoskeletal connective tissue cells with muscle: expression of muscle actin in and contraction of fibroblasts, chondrocytes, and osteoblasts
AU2002306835A1 (en) Composition and Methods for the Production of Biological Tissues and Tissue Constructs
Hwang et al. Assessments of injectable alginate particle-embedded fibrin hydrogels for soft tissue reconstruction
Sawyer et al. Perfusion directed 3D mineral formation within cell-laden hydrogels
AR034262A1 (en) A COMPOSITION TO PROVIDE AN INJECTABLE FLUID MIXTURE, A EQUIPMENT, A METHOD FOR PREPARING A MIXTURE OF SUCH EQUIPMENT, AN APPARATUS FOR THE INTRODUCTION OF A MIXTURE IN A PATIENT
Cui et al. Tissue-engineered pancreatic islets: culturing rat islets in the chitosan sponge
CA2541827C (en) Method for in situ repair of injured, damaged, diseased or aged articular cartilage using neo-cartilage constructs and a method for preparation thereof
Cerrato et al. Development and characterization of an equine skin‐equivalent model
Giang et al. Effective decellularization of human skin tissue for regenerative medicine by supercritical carbon dioxide technique
Gokyurek et al. 3D printed hydrogel scaffold promotes the formation of hormone-active engineered parathyroid tissue
Chang et al. Bone marrow mesenchymal stem cells form ectopic woven bone in vivo through endochondral bone formation
Kushnaryov et al. Evaluation of autogenous engineered septal cartilage grafts in rabbits: a minimally invasive preclinical model
Accolla et al. 3D printed elastomeric biomaterial mitigates compaction during in vitro vasculogenesis
Jeong et al. Autologous collagen-induced chondrogenesis using fibrin and atelocollagen mixture
EP3137594B1 (en) Method for producing a totally endogenous bioengineered tissue and tissue obtained thereby

Legal Events

Date Code Title Description
FA Abandonment or withdrawal